Home
Conditions
Recurrent Cancer

Clinical trial condition

Recurrent Cancer

Explore clinical trials studying Recurrent Cancer. Study availability and eligibility vary by location and protocol.

25 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Cancer trial results

Completed

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

NCT05415475

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +29 more
Locations: Shandong Second Provincial General Hospital Jinan, Shandong, China

View Trial Details

Completed

Empathetic Communication Facilitation Program for Early Initiation of End-of-life Discussions

NCT05045040

Conditions: Advanced Cancer, Behavior, Communication, +7 more
Locations: National Cancer Center Hospital, National Cancer Center Tokyo, Chuo-ku, Japan

View Trial Details

Completed

Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling

NCT03760952

Conditions: Adult Solid Tumor, Disease Attributes, Neoplasm Metastasis, +7 more
Locations: University of Chicago Chicago, Illinois, United States

Columbia University Medical Center New York, United States

University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States

Oncology Consultants Houston, Texas, United States

View Trial Details

Completed

TCR-engineered T Cells in Solid Tumors: IMA202-101

NCT03441100

Conditions: Cancer, Disease Attributes, Neoplasms, +6 more
Locations: University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States

University of Texas MD Anderson Cancer Center Houston, Texas, United States

Universitätsklinikum Würzburg Würzburg, Bavaria, Germany

Universitätsklinikum Bonn - Medizinische Klinik III Bonn, North Rhine-Westphalia, Germany

View Trial Details

Completed

Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy

NCT05990920

Conditions: Advanced Cancer, Advanced Solid Tumor, Disease Attributes, +12 more
Locations: Angeles Clinic and Research Institute Los Angeles, California, United States

Sarcoma Oncology Center Santa Monica, California, United States

View Trial Details

Completed

Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients

NCT05002140

Conditions: Disease Attributes, Locally Advanced Solid Tumor, Metastasis, +7 more
Locations: Stanford Clinical Cancer Center Stanford, California, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Recurrence After Whipple's (RAW) Study

NCT04596865

Conditions: Adenocarcinoma, Ampullary Cancer, Bile Duct Cancer, +35 more
Locations: Monash Medical Centre Clayton, Victoria, Australia

Medical University Innsbruck, Anichstr. 35 A Innsbruck, Austria

Azienda Ospedaliero - Universitaria Di Sassari Sassari, Sardinia, Italy

Azienda Ospedaliero - Universitaria Policlinico Umberto I Rome, Italy

View all 29 locations

View Trial Details

Completed

Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy

NCT03941262

Conditions: Advanced Cancer, Advanced Solid Tumor, Disease Attributes, +11 more
Locations: Sarcoma Oncology Research Center Santa Monica, California, United States

View Trial Details

Completed

Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma

NCT05364905

Conditions: Advanced Cancer, Disease Attributes, Endometrial Cancer, +20 more
Locations: Centre Hospitalier Victor Dupouy Argenteuil, France

Sainte-Catherine Institut du Cancer Avignon-Provence Avignon, France

CHRU Besançon - Hôpital Jean Minjoz Besançon, France

Guillaume BABIN Bordeaux, France

View all 30 locations

View Trial Details

Completed

IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors

NCT03758781

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +41 more
Locations: H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Recurrent Cancer

Recurrent Cancer trial results

Related conditions